Why we need a new crop of pharma leaders

Posted on January 18, 2017 by Richard Meyer

Reply

KEY TAKEAWAY: Some pharma company CEO’s are living in a bubble and don’t understand why consumers are angry at the pharma industry. Despite the fact that some cancer patients, for example, are living longer US consumers are sick of paying more for healthcare and prescription drugs. Continue reading →

Forbes asks “where are the pharma leaders?”

Posted on January 7, 2016 by Richard Meyer

Reply

KEY SUMMARY: Fobres, in a recent editorial, said “Pharma Needs A Leader In 2016” and I couldn’t agree more, but let’s be honest here, most pharma CEO’s are NOT leaders but rather high paid executives who bow to investor needs and demands. Continue reading →

Shareholders vs patients

Posted on May 27, 2015 by Richard Meyer

Reply

KEY TAKEAWAY: When shareholders are prioritized patients usually find themselves on the short end of the stick. Can the two ever live together?

Continue reading →

Pew: The FDA should be responsible for the safety of supplements.

KEY IDEA: A new survey finds that most American adults… more>>
Drop in the share of physicians seeing reps in-person

KEY DATA: According to DRG research share of physicians seeing… more>>
Why big pharma may be doomed

KEY THOUGHT: Pharma companies three on meetings. According to an… more>>
What’s important to pharma CEOs?

KEY THOUGHT: According to the Times “We’re in a world… more>>
The American healthcare system is unsustainable

PONTIFICATION: The headline read “Health Care Costs Are Eating Us… more>>
Should pharma adjust the DTC media mix?

KEY THOUGHT: Shifting more dollars into digital marketing might sound… more>>